Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Fujihara

Showing results (21-30 of 292) with videos related to

Pageof 30
Sort By:
Current Opinion in Neurology|April 13, 2016
Demyelinating diseases in AsiaHirofumi Ochi, Kazuo Fujihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Clinical concept, etiology and pathology of neuromyelitis optica]Kazuhiro Kurosawa, Kazuo Fujihara
Developmental Medicine and Child Neurology|February 7, 2018
Children with myelin oligodendrocyte glycoprotein antibodies-associated disease: relation of phenotypes to central nervous system myelin maturationHiroshi Kuroda, Kazuo Fujihara
Current Opinion in Neurology|May 7, 2020
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topicsKazuo Fujihara, Lawrence J Cook
Neurology|September 3, 2013
AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?Kazuo Fujihara, Douglas Kazutoshi Sato
Therapeutic Advances in Neurological Disorders|April 3, 2026
Neuromyelitis optica spectrum disordersMohammad Ali Sahraian, Kazuo Fujihara
Current Treatment Options in Neurology|September 16, 2010
Neuromyelitis opticaWilliam M Carroll, Kazuo Fujihara
Neurology|May 10, 2013
Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challengesKazuo Fujihara, Maria Isabel Leite
Frontiers in Neurology|October 4, 2023
Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwideJyh Yung Hor, Kazuo Fujihara
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 17, 2010
[A concept of neuromyelitis optica in Japan]Ichiro Nakashima, Kazuo Fujihara, Yasuto Itoyama
Pageof 30

Showing results (21-30 of 292) with videos related to

Sort By:
Pageof 30
Current Opinion in Neurology|April 13, 2016
Demyelinating diseases in AsiaHirofumi Ochi, Kazuo Fujihara
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Clinical concept, etiology and pathology of neuromyelitis optica]Kazuhiro Kurosawa, Kazuo Fujihara
Developmental Medicine and Child Neurology|February 7, 2018
Children with myelin oligodendrocyte glycoprotein antibodies-associated disease: relation of phenotypes to central nervous system myelin maturationHiroshi Kuroda, Kazuo Fujihara
Current Opinion in Neurology|May 7, 2020
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topicsKazuo Fujihara, Lawrence J Cook
Neurology|September 3, 2013
AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?Kazuo Fujihara, Douglas Kazutoshi Sato
Therapeutic Advances in Neurological Disorders|April 3, 2026
Neuromyelitis optica spectrum disordersMohammad Ali Sahraian, Kazuo Fujihara
Current Treatment Options in Neurology|September 16, 2010
Neuromyelitis opticaWilliam M Carroll, Kazuo Fujihara
Neurology|May 10, 2013
Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challengesKazuo Fujihara, Maria Isabel Leite
Frontiers in Neurology|October 4, 2023
Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwideJyh Yung Hor, Kazuo Fujihara
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 17, 2010
[A concept of neuromyelitis optica in Japan]Ichiro Nakashima, Kazuo Fujihara, Yasuto Itoyama
Pageof 30